TipRanks Another day, another buy recommendation for Bionano. After Bionano Genomics (BNGO) posted a slight earnings miss two months ago, Maxim analyst Jason McCarthy was so pessimistic about the company’s prospects that he lowered his price target on the San Diego-based cytogenetics specialist’s stock from $4 to $10. McCarthy is sticking to his updated prediction two months later, and in a note issued yesterday, he reiterated his “buy” recommendation on the company as well — and why not? He hasn’t done a doub in two months./n
Read MoreSundial Growers Inc. (SNDL) Stock Sinks As Market Gains: What You Should Know
2021-07-09T22:49:33-04:00July 9th, 2021|
Related Posts
-
Avoid This Stock Market Excitement
May 19th, 2024